PURPOSE: Previous investigations have suggested a strong association between sleep-disordered breathing (SDB) during pregnancy and perinatal outcomes. However, the results of the following replication studies were not always concordant. Therefore, this meta-analysis was conducted to evaluate the more reliable estimate. METHODS: A systematic literature search was performed on PubMed, Springer Link, and EMBASE to identify all eligible studies published before August 2013. Summary odds ratios (ORs) and 95% confidence intervals (CIs) were calculated using fixed or random effects model. RESULTS: A total of 24 publications met the inclusion criteria and were included in this meta-analysis. Findings demonstrated that moderate-to-severe SDB during pregnancy was associated with gestational diabetes mellitus (OR=1.78; 95% CI, 1.29 to 2.46), pregnancy-related hypertension (OR=2.38; 95% CI, 1.63 to 3.47), preeclampsia (OR=2.19; 95% CI, 1.71 to 2.80), preterm delivery (OR=1.98; 95% CI, 1.59 to 2.48), low birth weight (OR=1.75; 95% CI, 1.33 to 2.32), neonatal intensive care unit (NICU) admission (OR=2.43; 95% CI, 1.61 to 3.68), intrauterine growth restriction (OR=1.44; 95% CI, 1.22 to 1.71), and Apgar score of <7 at 1 min (OR=1.78; 95% CI, 1.10 to 2.91) based on all studies but not gestational age and birth weight. CONCLUSIONS: This meta-analysis revealed that moderate-to-severe SDB during pregnancy may be associated with most of adverse perinatal outcomes. Further well-designed studies are warranted to confirm our findings.
PURPOSE: Previous investigations have suggested a strong association between sleep-disordered breathing (SDB) during pregnancy and perinatal outcomes. However, the results of the following replication studies were not always concordant. Therefore, this meta-analysis was conducted to evaluate the more reliable estimate. METHODS: A systematic literature search was performed on PubMed, Springer Link, and EMBASE to identify all eligible studies published before August 2013. Summary odds ratios (ORs) and 95% confidence intervals (CIs) were calculated using fixed or random effects model. RESULTS: A total of 24 publications met the inclusion criteria and were included in this meta-analysis. Findings demonstrated that moderate-to-severe SDB during pregnancy was associated with gestational diabetes mellitus (OR=1.78; 95% CI, 1.29 to 2.46), pregnancy-related hypertension (OR=2.38; 95% CI, 1.63 to 3.47), preeclampsia (OR=2.19; 95% CI, 1.71 to 2.80), preterm delivery (OR=1.98; 95% CI, 1.59 to 2.48), low birth weight (OR=1.75; 95% CI, 1.33 to 2.32), neonatal intensive care unit (NICU) admission (OR=2.43; 95% CI, 1.61 to 3.68), intrauterine growth restriction (OR=1.44; 95% CI, 1.22 to 1.71), and Apgar score of <7 at 1 min (OR=1.78; 95% CI, 1.10 to 2.91) based on all studies but not gestational age and birth weight. CONCLUSIONS: This meta-analysis revealed that moderate-to-severe SDB during pregnancy may be associated with most of adverse perinatal outcomes. Further well-designed studies are warranted to confirm our findings.
Authors: Mary E Coussons-Read; Marci Lobel; J Chris Carey; Marianne O Kreither; Kimberly D'Anna; Laura Argys; Randall G Ross; Chandra Brandt; Stephanie Cole Journal: Brain Behav Immun Date: 2012-03-07 Impact factor: 7.217
Authors: Francesca L Facco; William A Grobman; Jamie Kramer; Kim H Ho; Phyllis C Zee Journal: Am J Obstet Gynecol Date: 2010-05-26 Impact factor: 8.661
Authors: K Champagne; K Schwartzman; L Opatrny; P Barriga; L Morin; A Mallozzi; A Benjamin; R J Kimoff Journal: Eur Respir J Date: 2009-02-12 Impact factor: 16.671
Authors: Stephen M Johnson; Karanbir S Randhawa; Jenna J Epstein; Ellen Gustafson; Austin D Hocker; Adrianne G Huxtable; Tracy L Baker; Jyoti J Watters Journal: Respir Physiol Neurobiol Date: 2017-11-22 Impact factor: 1.931
Authors: Galit L Dunietz; Giancarlo Vanini; Carol Shannon; Louise M O'Brien; Ronald D Chervin Journal: Sleep Med Rev Date: 2020-03-17 Impact factor: 11.609
Authors: Galit Levi Dunietz; Kerby Shedden; Lynda D Lisabeth; Marjorie C Treadwell; Louise M O'Brien Journal: Am J Hypertens Date: 2018-09-11 Impact factor: 2.689
Authors: Sarah S Farabi; Linda A Barbour; Kristy Heiss; Nicole M Hirsch; Emily Dunn; Teri L Hernandez Journal: J Clin Endocrinol Metab Date: 2019-07-01 Impact factor: 5.958